XePOHCAS - Xenon by Inhalation for Post Out of Hospital Cardiac Arrest Syndrome
XePOHCAS: Prospective, randomized, multicenter interventional trial in adult subjects with out-of-hospital cardiac arrest comparing treatment with standard-of-care post-cardiac arrest intensive care (which is targeted temperature management [TTM]) to xenon by inhalation plus standard-of-care post-cardiac arrest intensive care (including TTM).
100 项与 Invero Pharma 相关的临床结果
0 项与 Invero Pharma 相关的专利(医药)
100 项与 Invero Pharma 相关的药物交易
100 项与 Invero Pharma 相关的转化医学